CC BY
17
УДК 616.12-009.72-036.11(575.1)
DOI 10.52575/2687-0940-2022-45-2-152-165
Оригинальное исследование
Improvement of specialized medical care of patients with acute coronary syndrome in Tashkent city
Barno F. Mukhamedova, Shukhrat N. Salakhitdinov, Maftuna Kh. Nazarova,
Bekhzodbek O. Kazakov
Cardiologist at the Republican Research Centre of Emergency Medicine, 2 Kichik Halka Yuli St., Tashkent 100107, Uzbekistan E-mail: KBEXZODBEK@mail.ru
Abstract. The leading cause of death in the world and in the Republic of Uzbekistan is cardiovascular diseases, and their prevalence is increasing. To reduce morbidity and mortality from acute coronary syndrome, it is necessary to improve a high-tech specialized approach. As part of the implementation of the Government Decree of December 18, 2020 No. 341 «On improving the organization of emergency care for patients with» acute coronary syndrome «in Tashkent» to provide the most effective care for patients with coronary artery disease in terms of reducing mortality and disability, substantial investments have been made in the development of the cardiological service of Tashkent city. The main strategic direction of which is to provide the population with high-tech medical care in emergency cardiac conditions.
Keywords: Acute coronary syndrome, thrombolysis, percutaneous coronary intervention
For citation: Mukhamedova B.F., Salakhitdinov Sh.N., Nazarova M.Kh., Kazakov B.O. 2022. Improvement of specialized medical care of patients with acute coronary syndrome in Tashkent city. Challenges in Modern Medicine, 45 (2): 152-165 (in Russian). DOI: 10.52575/2687-0940-2022-45-2-152-165
Совершенствование специализированной медицинской помощи больных с острым коронарным синдромом в городе
Ташкенте
Мухамедова Б.Ф., Салахитдинов Ш.Н., Назарова М.Х., Казаков Б.О.
Республиканский научный центр экстренный медицинской помощи Узбекистана, Узбекистан, 100107, Ташкент, Чиланзарский район, ул. Кичик Халка Йули, 2 E-mail: KBEXZODBEK@mail.ru
Аннотация. Ведущей причиной смерти в мире и Республике Узбекистан являются сердечнососудистые заболевания, причем распространенность их возрастает. Для снижения заболеваемости и смертности от острого коронарного синдрома необходимо совершенствование высокотехнологичных специализированных подходов. В рамках реализации Постановления правительства от 18 декабря 2020 года № 341 «О совершенствовании организации неотложной медицинской помощи пациентам с острым коронарным синдромом в г. Ташкенте» для оказания наиболее эффективной помощи в плане снижения смертности и инвалидности больных с ИБС сделаны существенные инвестиции в развитие кардиологической службы г. Ташкента, основным стратегическим направлением которой является обеспечение высокотехнологичной медицинской помощи при неотложных кардиологических состояниях.
Ключевые слова: Острый коронарный синдром, тромболизис, чрескожное коронарное вмешательство
Для цитирования: Mukhamedova B.F., Salakhitdinov Sh.N., Nazarova M.Kh., Kazakov B.O. 2022. Improvement of specialized medical care of patients with acute coronary syndrome in Tashkent city. Challenges in Modern Medicine, 45 (2): 152-165 (in Russian). DOI: 10.52575/2687-0940-2022-45-2-152-165
Introduction
Despite the progress made in the treatment of cardiovascular diseases (CVDs) in developed countries, acute coronary syndrome (ACS) continues to be the main cause of morbidity and mortality among patients of different age groups. The majority of cases are coronary heart disease (CHD), especially its acute forms, which require expensive treatment with the introduction of endovascular and surgical methods of treatment into everyday clinical practice [Mamutov et al., 2013; Kozik et al., 2017; Kondakova et al., 2019; Crea et al., 2018; Nakashima, Tahara, 2018].
Reperfusion therapy is the main component of the treatment of patients with ACS with ST segment elevation. Its use in the early stages significantly improves the immediate long-term prognosis of the patient [Derevyanykh et al., 2018; Zaitseva et al., 2018; Inzhevatova, 2019; Gorbachev et al., 2020; O'Gara et al., 2010]. Various types of reperfusion are used in clinical practice. The most affordable is thrombolytic therapy, and the preferred one is primary percutaneous coronary intervention performed at a high professional level [Radushkevich et al., 2016; Kireev, Krasnopeev, 2018; Khachatryan et al., 2019; Mashchenko et al., 2019; Ibanez et al., 2018].
Expanding the possibility of using various types of percutaneous coronary intervention is especially important for patients with an initially increased risk of death, which increases tenfold depending on the number of adverse signs [Mamutov et al., 2013; Kireev et al., 2015; Usova,, Pechenkina, 2017; Ong et al., 2013; Kijpaisalratana et al., 2017]. In this regard, a quantitative assessment of the risk of death can be used to select patients for a primary percutaneous coronary intervention [Barbarash et al., 2018; Goloshchapov-Aksenov et al., 2018; Quinn et al., 2014].
Despite the absolute benefit of primary PCI in STEMI, economic, territorial, organizational, and social reasons prevent adherence to this standard in most European countries [Belova et al., 2017; Sagaydak et al., 2017; Goloshchapov-Aksenov et al., 2018; Derevyanykh et al., 2018; Markov et al., 2018; Biso et al., 2017]. Moreover, until recently, there was no clear understanding of the availability of primary PCI and the results of its use in real life. To address these issues in 2008 in Europe, the project of the European Association of the «Percutaneous Cardiovascular Interventional Initiative», «Stent for Life», began its work. The goal of this initiative is to introduce national programs for the organization of PCI in ACS to reduce mortality [Khusainova et al., 2018; Elgendy et al., 2017].
How is the generally recognized standard of adherence to primary PCI in patients with STEMI observed in Uzbekistan? Unfortunately, the lack of a functioning, full-fledged national registry for ACS in our country, associated with a number of objective difficulties, makes it extremely difficult to assess the availability of primary PCI for STEMI patients nationwide [Karimov et al., 2016].
As part of the implementation of the Government Decree of December 18, 2020, No. 341 «On Improving the Organization of Emergency Medical Care for Patients with Acute Coronary Syndrome in Tashkent», in order to provide the most effective care in terms of reducing mortality and disability for patients with coronary artery disease, significant investments have been made in the development of the cardiological service in Tashkent. The main strategic direction of this cardiological service is to provide the population with high-tech medical care in emergency cardiological conditions.
The aim of this paper is to improve care delivery and patient access to life-saving primary percutaneous coronary intervention, thereby reducing mortality and morbidity in patients with acute coronary syndrome (ACS).
Material and research methods
By order No. 341 «On improving the organization of emergency medical care for patients with acute coronary syndrome in Tashkent», patients with a diagnosis of ACS and ST segment elevation should be provided the most effective emergency medical care as follows:
Emergency medical care should be provided to patients with acute coronary syndrome with ST elevation in Tashkent at the Republican Research Centre for Emergency Medicine 24 hours a day,, and primary PCI should be provided to patients at the Republican Specialized Scientific and Practical Medical Centre for Cardiology and the Republican Specialized Scientific and Practical Medical Centre for Surgery from 9.00 (the start of service posts function) until 17.00.
A list of districts that are part of the Republican Research Centre of Emergency Medicine (RRCEM), Republican Specialized Scientific and Practical Medical Centre for Surgery (RSSPMCS), and Republican Specialized Scientific and Practical Medical Centre for Cardiology (RSSPMCC) is shown in Table 1.
Table 1 Таблица 1
Names of specialized scientific and practical centres and districts of the city of Tashkent in which they are
located
Перечень специализированных научно-практических медицинских центров и районов города
Ташкента, в которых они расположены
№ Region Names of the specialized scientific and practical centres Name of the annexed districts
1. Tashkent city Republican Research Centre of Emergency Medicine (RRCEM) Shaykhontohur Yakkasaray Sergeli Mirobod Yashnobod Yangi Hayot
Republican Specialized Scientific and Practical Medical Centre for Surgery (RSSPMCS) Uchtepa Olmazar Chilanzar
Republican Specialized Scientific and Practical Medical Centre for Cardiology (RSSPMCC) Yunusabad Mirzo-Ulugbek Bektemir
Our study was conducted at the RRCEM. This medical organization provides specialized cardiological and X-ray endovascular medical care to patients with acute coronary pathology around the clock (7 days for 24 hours).
To assess the immediate results of the treatment of ACS and AMI, a retrospective analysis of the annual statistical reports of the Department of Emergency Cardiology and Angiography of the RRCEM for 2019-2021 was carried out.
Research results
From 2019 to 2021, the number of people diagnosed with ACS increased by 62,3 %. In 2019, 1888 cases of ACS were registered at the RRCEM. Of these, ACS with ST segment elevation (ACS|ST) accounted for 51,4 % (972), and the percentage of patients with ACS without ST elevation (ACSwST) was 48,6 % (916). Among the outcomes of ACS|ST, MI with Q developed in 50,4 % (950) of patients, and MI without Q developed in 14,6 % (276) of patients. Unstable angina (UA) developed in 31,1 % (588) of patients, and other diseases were observed in 3,9 % (74).
In 2020, 1050 cases of ACS were registered at the RSECMA. Due to the pandemic, the overall patient population has decreased. Of these, ACS with ST segment elevation (ACS|ST) accounted for 66,2 % (696), and the percentage of patients with ACS without ST elevation (ACSwST) was 33,8 % (354). Among the outcomes of ACS|ST, MI with Q developed in 58,2 % (611) of patients, and MI without Q developed in 12,4 % (131) of patients. Unstable angina (UA) occurred in 15,9 % (285) of patients, and other diseases occurred in 2,2 % (23).
In 2021, 2074 cases of ACS were registered at the RSECMA. Of these, ACS with ST segment elevation (ACS|ST) accounted for 65,2 % (1352), and the percentage of patients with ACS without ST elevation (ACSwST) was 34,8 % (722). Among the outcomes of ACS|ST, MI with Q developed in 53,1 % (1100) of patients, and MI without Q developed in 11,8 % (245) of patients. Unstable angina (UA) occurred in 30,2 % (626) of patients, and other diseases occurred in 4,9 % (103) (Fig. 1).
■ ACS-TST ■ ACSwST ■ Ml with Ct Q IMIwithoutQ
■ unstable angina (UA) ■ other diseases
65,20%
2019 2020 2021 2019 2020 2021
Fig. 1. Frequency of occurrence in ACS Рис 1. Частота встречаемости ОКС
In 2021, the largest number of coronary angiographies (CAG) was performed at RRCEM for the entire period of work in this area, 1356. Relative to 2019, during which 414 examinations, this represents a significant increase of 30,3 times. In 2019, emergency percutaneous coronary interventions in patients with ACS and AMI were performed at the RRCEM in isolated cases. Until 2020, only the residents of 2 districts (Chilanzar and Sergeli districts) with ACS applied to the RRCEM, where emergency PCI was performed only until 14:00 on a working day. Other residents of Tashkent with a diagnosis of ACS applied to other medical institutions. Until 2020, the only reperfusion treatment used was thrombolytic therapy.
In 2019, 218 urgent percutaneous coronary interventions were performed; by 2021, this figure had increased by 89,3 times, amounting to 1100 operations. The proportion of patients with AMI who underwent coronary angiography and percutaneous coronary intervention (PCI) is presented in Table 2.
In 2019, 57,7 % of patients with ACS|ST and 77,7 % of all patients with ACS were taken to hospitals by an emergency medical team within the first 6 hours of illness onset.
By order № 341 of 2021, all patients with ACS must be delivered to hospitals by ambulance teams. Thus, in 2021, 89,9 % of patients with ACS and 91,5 % of ACS|ST patients were delivered by ambulance teams.
Table 2 Таблица 2
Number of patients with AMI who underwent coronary angiography and percutaneous coronary
interventions over 3 years Количество больных с ОИМ, подвергнутых КАГ и чрескожным коронарным вмешательствам в
течение 3 лет
Year CAG PCI
2019 414 950
2020 917 611
2021 1356 1100
Given the widespread use of reperfusion therapy methods for myocardial infarction with ST segment elevation, the choice of optimal treatment tactics requires an objective assessment of the severity of the patient's condition, starting from the prehospital stage. Taking into account the timing of anginal status and the available opportunities, preference is given to the use of pharmacological or mechanical reperfusion, the use of certain drugs, and measures to reduce the delay at all stages until complete reperfusion is achieved.
Studies evaluating the effectiveness of thrombolytic therapy have found significant differences in mortality depending on a number of factors. It has been established that in patients under the age of 45 years, mortality during the first 30 days is 2,1 %, from 45 to 55 years - 3,4 %, and from 65 to 75 years - 24,3 %. The risk factors for the occurrence of ACS are presented in Table 3.
Table 3 Таблица 3
Risk factors for ACS Факторы риска возникновения ОКС
Risk factors for patients with ACS Number of patients (n %
2019 2020 2021
Arterial hypertension (AH) 947 (50,1 %) 784 (74,6 %) 1850 (89,2 %)
Diabetes 568 (30,1 %) 621 (59,1 %) 1063 (51,2 %)
Smoking 956 (50,6 %) 841 (80,1 %) 1926 (92,8 %)
Dyslipidaemia 421 (22,3 %) 482 (45,9 %) 768 (37,3 %)
Cases of sudden death in the family 123 (6,5 %) 95 (9 %) 157 (7,5 %)
The frequency of previous cardiac history in patients with ACS is presented in Table 4.
Table 4 Таблица 4
Frequency of prior cardiac history in patients with ACS Частота сердечно-сосудистой патологии в анамнезе у пациентов с ОКС
Previous cardiac history in patients with ACS Number of patients (n) %
2019 2020 2021
Suffered a myocardial infarction (MI) 950 (50,3 %) 611 (58,2 %) 1100 (53,1 %)
History of stable angina pectoris (SEA) 1088 (5 %) 521 (49,6 %) 2001 (96,4 %)
Unstable angina (UA) 738 (39 %) 239 (22,7 %) 874 (42,1 %)
Hypertension (HT) 947 (5 %) 784 (74,6 %) 1850 (89,2 %)
Chronic heart failure (CHF) 30 (1,5 %) 32 (30,4 %) 54 (2,6 %)
Coronary artery bypass grafting (CABG) performed 5 (0,3 %) 7 (0,6 %) 8 (0,38 %)
Oncological diseases 2 (0,28 %) 4 (0,38 %) 8 (0,38 %)
Diseases of the gastrointestinal tract 30 (1,6 %) 36 (3,4 %) 47 (2,23 %)
The unfavourable prognostic significance of these and a number of other factors allows formation of an objective idea of the severity of the patient's condition, while an external examination, especially after pain relief, may be less informative. In this regard, several methods for quantitative risk assessment have been proposed. The simplest is the method developed by the TIMI group. It identifies eight independent predictors of death, allowing stratification of patients with a probability of death from 0,8 % to 35,9 % (Table 5).
Table 5 Таблица 5
Independent Predictors of Death in TIMI Risk Quantification Scores Независимые предикторы смерти в баллах при количественной оценке риска TIMI
No. Predictors Points
Age:
1. Over 75 years old 3
Over 65 years old 2
2. IHD/AH/DM history 1
3. T ST V2-6/acute LBBB 1
4. DOS II-IV degree according to Killip 2
5. HR > 100 beats per minute 2
6. Systolic BP < 100 mmHg 3
7. Weight < 67 kg 1
8. No reperfusion therapy in the first 4 hours 1
Based on the number of points reflecting their significance, the predictors can be divided into 3 groups: low, medium and high risk.
It is generally accepted that percutaneous coronary interventions are the preferred method of reperfusion therapy. However, even in RRCEM with the possibility of their 24-hour use, late admission to the hospital is the reason for refusal of reperfusion therapy. According to our data, in 2019, 950 visits with a diagnosis of myocardial infarction with ST segment elevation were registered at the RSECMA; only 45 % of these patients were admitted within the first 12 hours, and reperfusion therapy was performed in 60 %.
In 2020, out of 611 patients diagnosed with myocardial infarction with ST segment elevation, 45 % were admitted within the first 12 hours, and reperfusion therapy was performed in 60 %. In 2021, out of 1100 patients, 70 % diagnosed with myocardial infarction with ST segment elevation were admitted within the first 12 hours, and reperfusion therapy was performed in 90 %.
For revascularization in patients with ST elevation MI, the severity of the patient's condition should be determined in the first 24 hours from the onset of the disease. The emergency physician should be able to determine the severity of the patient's condition to solve the problem of transporting the patient to the RRCEM hospital.
List of indications for transporting patients with ACS to a hospital with the possibility of PCI:
1) Pin syndrome and ST segment elevation on ECG or ACS|ST or newly diagnosed blockade of the left bundle branch block if TLT is contraindicated or impossible for ensuring delivery of the patient to the hospital in the first 12 hours from the onset of the pain syndrome;
2) ACS|ST if the performed TLT is ineffective for ensuring delivery of the patient to a hospital with the possibility of PCI;
3) ACSwST with a recurrent nature of anginal pain in the presence of ST segment depression > 2 mm in more than two adjacent leads or a positive troponin test;
4) ACS complicated by life-threatening arrhythmias and conduction disorders.
Contraindications for transporting patients with ACS to a hospital with the possibility of PCI:
1) decompensated somatic pathology (renal and liver failure, acute pancreatitis, haemor-rhagic diseases, severe anaemia, ulcerative lesions of the gastrointestinal tract in the acute stage, signs of ongoing bleeding, stage IV chronic heart failure);
2) oncological diseases in the stage of metastasis (III-IV stage, documented);
3) active forms of tuberculosis;
4) acute infectious processes;
5) mental illness with a personality defect;
6) dementia;
7) coma of unknown origin;
8) refusal of treatment (PCI).
Over the 3 years, 1183 (895 males, 288 females) patients with acute myocardial infarction with ST-segment elevation out of 2661 patients underwent PCI. Of these, 425 patients (36 %) had primary anterior MI, 354 (30 %) had primary lower MI, 94 (8 %) had involvement of circular infarction, and 310 (26 %) had recurrent MI. In all cases, a quantitative assessment of the risk of death according to TIMI was carried out. In 54 % of cases, the risk was high, in 18 % - medium, and in 28 % - low. Most patients with primary anterior infarction, involvement of circular MI, and recurrent myocardial infarction had a high baseline risk of death, while patients with primary inferior infarction had a low baseline risk (Fig. 2).
■ high ■ medium ■ low
81%
Primary anterior Primary inferior Ml Recurrent Ml Circulation Ml
Ml, n=482 n=266 n=351 n=84
Fig. 2. Distribution of patients with different locations of MI divided by risk group according to TIMI Рис. 2. Распределение больных с различной локализацией ИМ в зависимости от групп риска по
TIMI
The distribution of patients with ACS with ST segment elevation by type of treatment is presented in Table 6.
Table 6 Таблица 6
Distribution of patients with ST-segment elevation ACS by type of treatment Распределение больных с ОКС с подъемом сегмента ST по виду лечения
Total number of patients With PCI Without PCI
(n) (n) % (n) %
2019 1888 950 (50,3 %) 938 (49,7 %)
2020 1050 611 (58,2 %) 439 (41,8 %)
2021 2074 1100 (53 %) 974 (47 %)
Percutaneous coronary interventions (PCIs) in the first 12 hours were performed regardless of the risk of death. In the first 12 hours, they accounted for only 5,1 ± 5,53 % of all primary interventions (Fig. 3).
■ PCI in the first 12 hours ■ PCI in the first 24 hours I PCI on days 2-5
2021
Fig. 3. Primary PCI according to the timing of the implementation in the acute period of MI Рис. 3. Первичные ЧКВ зависимости от сроков выполнения в остром периоде ИМ
Over the three 3 years, percutaneous coronary interventions in the form of balloon angioplasty and stenting of the infarct-associated artery were performed for 1076 and 1574 patients, respectively. Regardless of the timing of the use of the primary percutaneous coronary intervention, stenting was performed for all patients (Fig. 4).
■ Stenting ■ Translumbar balloon angioplasty (TLBAP)
2019 2020 2021
Fig. 4. Primary PCI according to the strategy of their application Рис. 4. Первичные чрескожные коронарные вмешательства в зависимости от стратегии их
применения
At the RSECMA, mortality from AMI in 2019-2020, when coronary interventions were not used in the treatment of ACS with ST elevation, was unchanged (approximately 11 %). The three-year mortality from 2019 to 2021 among patients with AMI at the RRCEM decreased to 8,9 % (2019 - 11 %, 2020 - 9,9 %, 2021 - 8,9 %) (Fig. 5).
Летальность
2019г 2020г 2021г
21,48
49,17 %
%
29,34
%
ЧКВ БезЧКВ
8,90%
8,20%
2019г 2020г 2021r
А Б
Fig. 5. Hospital mortality rate in patients with ACS (A), Hospital mortality according to the treatment
strategy for ACS (B)
Рис. 5. Частота госпитальной летальности у больных ОКС (А), госпитальная летальность в
зависимости от стратегии лечения в ОКС (Б)
Discussion of the results
The data obtained show that the number of patients with ACS|ST was 1,5 times higher than the number of patients with ACSwST. More than 82 % of patients had high blood pressure, one in three had angina pectoris, and more than half had an acute cardiovascular event (IM, UA).
The presented data emphasize the importance of using primary percutaneous coronary interventions as early as possible. Among the patients who died, 59 % died from 12 to 24 hours
from the moment of admission, while the rest (41 %) died after 3 days at the earliest. In the absence of differences in the initial risk of death, mortality among patients without reperfusion therapy was 5 times higher than in patients with primary PCI.
As a basis for selecting patients for primary percutaneous coronary interventions, we selected those with an increased risk of death, determined by the TIMI scale, and stratified patients with a probability of death ranging from 0,8 to 24,6 %. Given the high mortality among patients with anterior infarction, right ventricular involvement, and recurrent infarction, we considered it appropriate to use primary PCI in cases where the initial risk of death according to TIMI was not increased.
Our data indicate that primary percutaneous coronary interventions performed in the acute period of myocardial infarction can significantly reduce the incidence of complications and significantly increase survival. The indications for their use may be based on an increased risk of death according to TIMI.
Thus, regarding the optimal method for performing reperfusion therapy for STEMI, a clear understanding of the unconditional advantage of primary PCI was achieved, and recommendations were developed with absolute indications for this reperfusion strategy for STEMI. Nevertheless, work in this direction is just beginning in our country, and in this regard, the experience of foreign colleagues should be taken as the most important guideline.
Conclusions
1. Analysis of the effectiveness of an invasive strategy for the treatment of patients with ACS shows that PCI is a promising direction for preventing mortality and reducing morbidity and disability from coronary artery disease.
2. To improve the results of PCI for ACS, it is necessary to minimize the time from the patient's presentation to the provision of specialized care in hospitals with an angiocardiography department operating 7 days a week, 24 hours a day.
3. Increasing public awareness about acute heart attack and the availability of high-tech methods of treatment in order to timely seek medical help is important.
4. The work of the ambulance system and hospitals should be organized according to a single algorithm based on common principles for the diagnosis and treatment of ACS and a common understanding of tactical issues.
5. Ongoing staff training should be conducted at all stages of care for patients with ACS.
References
Barbarash O.L., Kashtalap V.V., Polikutina O.M., Klimenkova A.V. 2018. Non-ST-segment elevation acute coronary syndrome. Peculiarities of pre-hospital diagnostics. Emergency Cardiology 1: 3-15. Belova S.A., Lukin O.P., Belov D.V., Peshikov O.V., Arefyev N O. 2017. Roughing of patients with diseases of the circulation system when providing high-tech medical care on the example of the Chelyabinsk region. Bulletin of the Council of Young Scientists and Specialists of the Chelyabinsk Region. T. 2., 3 (18): 46-50. Goloshchapov-Aksenov R.S., Semenov V.Yu., Lakunin K.Yu., Kicha D.I., Bazhenova A.I. 2018. Experience of use of medico-economic standards for the endovascular treatment of diseases. Health Manager 1: 52-60.
Gorbachev V.I., Antipina L.G., Gorbacheva S.M. 2020. Regulatory aspects of thrombolysis in acute coronary syndrome. Farmateka 27 (3): 118-121. https://dx.doi.org/10.18565/pharmateca. 2020.3.118-121
Derevyanykh E.V., Gorbachev I.I., Shvetsova E.D., Fomin V.V., Seredenko A.A. 2018. Diagnosis of
acute coronary syndrome. National health. 4: 49-52. Zaitseva T.V., Loifman V.M., Rudman V.Ya., Teryaev S.A., Kalashnikov K.A., Pugachev K.N., Lukyanchikova V.F., Berezhnaya L.G., Morozova E.A., Buketova I.F., Baryshko S.Yu. 2018. Organization of medical care for patients with acute coronary syndrome (on the facilities of the Primary Vascular Department of the Khabarovsk Krai Clinical Hospital No. 1 named after Professor S.I. Sergeyev). Public Health of the Far East 4 (86): 13-18.
Inzhevatova A.E., Shatalova M.S., Morozov A.M. 2019. Materials of the 65th All-Russian Interuniversity Scientific Conference with International Participa. Modern methods of treatment of acute coronary syndrome Youth, science, medicine . Tver: State Budgetary Educational Institution of Higher Professional Education Tver State Medical Academy of the Ministry of Health of the Russian Federation. pp. 422-425.
Karimov U.B., Mamasaliev N.S., Erlikh A.D. 2016. Acute coronary syndromes in the Ferghana Valley of Uzbekistan: Ways to optimize treatment. Science yesterday, today, tomorrow. 2 (1): 48-56.
Kireev K.A., Krasnopeev A.V. 2018. Efficacy of the hospital algorithm of selection for coronary interventions in acute coronary syndrome. Russian Journal of Endovascular Surgery 5 (4): 445-51. https://doi.org/10.24183/2409-4080-2018-5-4-445-451
Kireev K.A., Moskvichjova M.G, Fokin A.A., Kireeva T.S. 2015. Patient Routing and Choice of Reperfusion Therapy for Acute Coronary Disease (the Experience of the Chelyabinsk Region). Bulletin of the South Ural State University. Ser. Education, Healthcare Service, Physical Education. 15 (1): 52-58.
Kozik V.A., Lozhkina N.G., Glebchenko E.A., Khasanova M.H., Kuimov A.D. 2017. Acute coronary syndrome modern strategy reperfusion and medication. Modern Problems of Science and Education. Surgery 1: 38-45.
Kondakova N.A., Shirokikh I.V. 2019. Abstracts of the VIII International Youth Medical Congress. Evaluation of the effectiveness of the introduction of measures to route patients with acute coronary syndrome (118-119). St. Petersburg.
Mamutov R.S., Urinov O., Bekbulatova I.R., Anarbayeva M.R., Abidova D.E. 2013. Clinico-epidemiological study of acute coronary syndrome/acute myocardial infarction: data from the tashkent city district register. Cardiovascular therapy and prevention 12 (3): 10-17. https://doi.org/10.15829/1728-8800-2013-3-10-17
Markov D.S., Ogneva E.I., Gurov A.N. 2018. The specialized medical care support of patients with acute disorders of cardio-vascular system in vascular centers of the Moscow region. Problems of Social Hygiene, Public Health and History of Medicine 26 (5): 320-323. https://doi.org/10.32687/0869-866X-2018-26-5 -320-323
Mashchenko D.V., Krupovich A.Ya., Shagzhiev B.E. 2019. Medicine of tomorrow: Materials of the XVIII Interregional Scientific and Practical Conference of Students and Young Scientists Analysis of temporal indicators of routing of patients with acute coronary syndrome with st-segment elevation. Chita: Chita State Medical Academy pp. 17-18.
Radushkevich VL., Rozhkov S.A., Okunevsky A.I., Chursin A.A., Vakhtina E.B., Boev D.E. 2016. Organizational aspects prehosppital care in acute coronary syndromes in the Voronezh region. Emergency medical care 17 (4): 15-20. https://doi.org/10.24884/2072-6716-2016-17-4-15-20
Sagaydak O.V., Oshchepkova E.V., Popova Yu.V., Kiselev A.R., Kolosova I.D., Gridnev V.I. 2017. Approaches to optimization of acute coronary syndrome patients care timing characteristics in federal acute coronary syndrome registry system and Russian Ministry of health monitoring system. Kardiologicheskii Vestnik. 12 (4): 82-87.
Usova T.E., Pechenkina M.V. 2017. Collection of the 71st interuniversity (VI All-Russian) final scientific student conference with international participation. Frequency of use of thrombolytic therapy in acute coronary syndrome. Chelyabinsk: Federal State Budgetary Educational Institution of Higher Education «South Ural State Medical University» of the Ministry of Health of the Russian Federation. pp. 213-214.
Khachatryan G.I., Raskatova E.V., Vartanov P.V., Belyakov G.A., Stepanyan A.V., Madaminov I.Ya., Abdullaev A.B., Mansurov S.K., Sirotskaya E.V. 2019. Results of endovascular treatment for ST-segment elevation myocardial infarction in a regional vascular center. Russian Journal of Endovascular Surgery 6 (1): 44-51. https://doi.org/10.24183/2409-4080-2019-6-1-44-51
Khusainova D.F., Kholkin I.V., Sokolova L.A. 2018 Monitoring of the quality of thrombolytic therapy in case of acute coronary syndrome at pre-hospital stage. Therapy. 7 (25): 106-110. https: // dx.doi.org/10.18565/
Banez B., James S., Agewall S. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European
Society of Cardiology (ESC). European heart journal 39 (2): 119-177. https://doi.org/10.1093/eurheartj/ehx393 Biso S.M., Lu M., De Venecia T.A., Wongrakpanich S., Rodriguez-Ziccardi M., Yadlapati S., Kishlyansky M., Rammohan H.S., & Figueredo, V.M. 2017. Clinical Characteristics, Management, and Outcomes of Suspected Poststroke Acute Coronary Syndrome. Cardiology research and practice, 1-6. http://doi.org/10.1155/2017/3762149 Elgendy I.Y., Mahmoud A.N., Kumbhani D.J., Bhatt D.L., Bavry A.A. 2017. Complete or culprit-only revascularization for patients with multivessel coronary artery disease undergoing percutaneous coronary intervention: a pairwise and network meta-analysis of randomized trials. JACC Cardiovasc Interv. 10 (4): 15-324. https://doi.org/10.1016/j.jcin.2016.11.047 Crea F., Binder R.K., Luscher T.F. (2018) The year in cardiology 2017: acute coronary syndromes.
European heart journal 39 (13): 1054-1064. http://doi.org/10.1093/eurheartj/ehx781 Nakashima T., Tahara Y. 2018. Achieving the earliest possible reperfusion in patients with acute coronary
syndrome: a current overview. J. intensive care. 6:20. https://doi.org/10.1186/s40560-018-0285-9 Kijpaisalratana N., Chutinet A., Suwanwela N.C. 2017. Hyperacute Simultaneous Cardiocerebral Infarction: Rescuing the Brain or the Heart First? Frontiers in neurology 8:664. https://doi.org/10.3389/fneur.2017.00664 O'Gara P.T., Kushner F.G., Ascheim D.D., et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 127: e362-425. https://doi.org/10.1161/cir.0b013e3182742cf6 Ong M.E., Wong A.S., Seet C.M., et al. 2013. Nationwide improvement of door-to-balloon times in patients with acute ST-segment elevation myocardial infarction requiring primary percutaneous coronary intervention with out-of-hospital 12-lead ECG recording and transmission. Ann Emerg Med. 61: 339-347. https://doi.org/10.1016/j.annemergmed.2012.08.020. Quinn T., Johnsen S., Gale C.P., et al. 2014. Effects of prehospital 12-lead ECG on processes of care and mortality in acute coronary syndrome: a linked cohort study from the Myocardial Ischaemia National Audit Project. Heart. 100: 944-950. https://doi.org/10.1136/heartjnl-2013-304599
Список литературы
Барбараш О.Л., Кашталап В.В., Поликутина О.М., Клименкова А.В. 2018. Острый коронарный синдром без подъема сегмента ST. особенности догоспитальной диагностики. Неотложная кардиология. 1: 3-15.
Белова С.А., Лукин О.П., Белов Д.В., Пешиков О.В., Арефьев Н.О. 2017. Особенности маршрутизации пациентов с ишемической болезнью сердца в Челябинской области. Вестник Совета молодых учёных и специалистов Челябинской области. Т. 2., 3 (18): 46-50. Голощапов-Аксенов Р.С., Семенов В.Ю., Лакунин К.Ю., Кича Д.И., Баженова А.И. 2018. Опыт использования медико-экономических стандартов лечения заболеваний с применением рентгенэндоваскулярных диагностики и лечения // Менеджер здравоохранения. 1: 52-60. Горбачев В.И., Антипина Л.Г., Горбачева С.М. 2020. Нормативные аспекты проведения тромболизиса при остром коронарном синдроме. Фарматека. 27 (3): 118-121. https://dx.doi.org/10.18565/pharmateca.2020.3.118-121 Деревянных Е.В., Горбачев И.И., Швецова Е.Д., Фомин В.В., Середенко А.А. 2018. Диагностика
острого коронарного синдрома. Национальное здоровье. 4: 49-52. Зайцева Т.В., Лойфман В.М., Рудман В.Я., Теряев С.А., Калашников К.А., Пугачев К.Н., Лукьянчикова В.Ф., Бережная Л.Г., Морозова Е.А., Букатова И.Ф., Барышко С.Ю. 2020. Организация медицинской помощи больным при остром коронарном синдроме. Здравоохранение Дальнего Востока. 4 (86): 13-18. Инжеватова А.Е., Шаталова М.С., Морозов А.М. 2019. Современные методы лечения острого коронарного синдрома. В сборнике: Молодежь, наука, медицина. Материалы 65-й Всероссийской межвузовской студенческой научной конференции с международным участием. С. 422-425.
Каримов У.Б., Мамасалиев Н.С., Эрлих А.Д. 2016. Острые коронарные синдромы в Ферганской долине Узбекистана: Пути оптимизации лечения. Наука вчера, сегодня, завтра. 2 (1): 48-56.
Киреев К.А., Краснопеев А.В. 2018. Оценка эффективности госпитального алгоритма отбора на коронарные вмешательства при остром коронарном синдроме. Эндоваскулярная хирургия. 5 (4): 445-451. https://doi.org/10.24183/2409-4080-2018-5-4-445-451 Киреев К.А., Москвичёва М.Г., Фокин А.А., Киреева Т.С. 2015. Маршрутизация больных и выбор реперфузионной терапии при острой коронарной патологии (опыт Челябинской области). Вестник Южно-Уральского государственного университета. Серия: Образование, здравоохранение, физическая культура. 15 (1): 52-58. Козик В.А., Ложкина Н.Г., Глебченко Е.А., Хасанова М.Х., Куимов А.Д. Острый коронарный синдром: современные стратегии реперфузии и медикаментозного лечения. Современные проблемы науки и образования. - 2017. - № 1. - С. 38-45. Кондакова Н.А., Широких И.В. 2019. Оценка эффективности введения мер по маршрутизации больных с острым коронарным синдромом. В книге: Санкт-Петербургские научные чтения - 2019. Тезисы VIII международного молодежного медицинского конгресса. Санкт-Петербург, С. 117. Мамутов Р.Ш., Уринов О., Бекбулатова И.Р., Анарбаева М.Р., Абидова Д.Э. 2013. Клинико-эпидемиологическое изучение острого коронарного синдрома/острого инфаркта миокарда по данным регистра в одном из районов г. Ташкента. Кардиоваскулярная терапия и профилактика. 12 (3): 10-17. Марков Д.С., Огнева Е.Ю., Гуров А.Н. 2018. Организация оказания специализированной медицинской помощи пациентам с острыми нарушениями сердечно-сосудистой системы в сосудистых центрах Московской области. Проблемы социальной гигиены, здравоохранения и истории медицины. 26 (5): 320-323. https://doi.org/10.32687/0869-866X-2018-26-5-320-323 Мащенко Д.В., Крупович А.Я., Шагжиев Б.Э. 2019. Анализ временных показателей маршрутизации больных с острым коронарным синдромом с подъемом сегмента st. В книге: Медицина завтрашнего дня. Материалы XVIII Межрегиональной научно-практической конференции студентов и молодых ученых. Сборник научных трудов. С. 17-18. Радушкевич В.Л., Рожков С.А., Окуневский А.И., Чурсин А.А., Вахтина Е.Б., Боев Д.Е. 2016. Организационные аспекты догоспитальной медицинской помощи при остром коронарном синдроме на территории Воронежской области. Скорая медицинская помощь. 17 (4): 15-20. https://doi.org/10.24183/2409-4080-2019-6-1-44-51 Сагайдак О.В., Ощепкова Е.В., Попова Ю.В., Киселев А.Р., Коносова И.Д., Гриднев В.И. 2017. Подходы к оптимизации временных показателей оказания медицинской помощи больным с острым коронарным синдромом в системе федерального регистра острого коронарного синдрома и мониторинга Минздрава России. Кардиологический вестник. 12 (4): 82-87. Усова Т.Е., Печенкина М.В. 2017. Частота использования тромболитической терапии при остром коронарном синдроме. В сборнике: Сборник 71-й межвузовской (VI Всероссийской) итоговой научной студенческой конференции с международным участием. С. 213-214. Хачатрян Г.И., Раскатова Е.В., Вартанов П.В., Беляков Г.А., Степанян А.В., Мадаминов И.Я., Абдуллаев А.Б., Мансуров С.К., Сиротская Е.В. 2019. Результаты рентгенэндоваскулярного лечения острого коронарного синдрома с подъемом сегмента st на базе регионального сосудистого центра. Эндоваскулярная хирургия. 6 (1): 44-51. https://doi.org/10.24183/2409-4080-2019-6-1-44-51
Хусаинова Д.Ф., Холкин И.В., Соколова Л.А. 2018. Мониторинг качества тромболитической терапии при остром коронарном синдроме на догоспитальном этапе. Терапия. 7 (25): 106-110. https: //dx.doi.org/10.18565 Banez B., James S., Agewall S. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European heart journal 39 (2): 119-177. https://doi.org/ 10.1093/eurheartj/ehx393 Biso S.M., Lu M., De Venecia T.A., Wongrakpanich S., Rodriguez-Ziccardi M., Yadlapati S., Kishlyansky M., Rammohan H.S., & Figueredo, V.M. 2017. Clinical Characteristics, Management, and Outcomes of Suspected Poststroke Acute Coronary Syndrome. Cardiology research and practice, 1-6. http://doi.org/10.1155/2017/3762149 Elgendy I.Y., Mahmoud A.N., Kumbhani D.J., Bhatt D.L., Bavry A.A. 2017. Complete or culprit-only revascularization for patients with multivessel coronary artery disease undergoing percutaneous
coronary intervention: a pairwise and network meta-analysis of randomized trials. JACC Cardiovasc Interv. 10 (4): 15-324. https://doi.org/10.1016/j.jcin.2016.11.047 Crea F., Binder R.K., Luscher T.F. (2018) The year in cardiology 2017: acute coronary syndromes.
European heart journal 39 (13): 1054-1064. http://doi.org/10.1093/eurheartj/ehx781 Nakashima, T., Tahara, Y. 2018. Achieving the earliest possible reperfusion in patients with acute coronary
syndrome: a current overview. J. intensive care. 6: 20. https://doi.org/10.1186/s40560-018-0285-9 Kijpaisalratana N., Chutinet A., Suwanwela N.C. 2017. Hyperacute Simultaneous Cardiocerebral Infarction: Rescuing the Brain or the Heart First? Frontiers in neurology 8: 664. https://doi.org/10.3389/fneur.2017.00664 O'Gara P.T., Kushner F.G., Ascheim D.D. et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 127: e362-425. https://doi.org/10.1161/cir.0b013e3182742cf6 Ong M.E., Wong A.S., Seet C.M. et al. 2013. Nationwide improvement of door-to-balloon times in patients with acute ST-segment elevation myocardial infarction requiring primary percutaneous coronary intervention with out-of-hospital 12-lead ECG recording and transmission. Ann Emerg Med. 61: 339-347. https://doi.org/10.1016/j.annemergmed.2012.08.020. Quinn T., Johnsen S., Gale C.P., et al. 2014. Effects of prehospital 12-lead ECG on processes of care and mortality in acute coronary syndrome: a linked cohort study from the Myocardial Ischaemia National Audit Project. Heart. 100: 944-950. https://doi.org/10.1136/heartjnl-2013-304599
Conflict of interest: no potential conflict of interest related to this article was reported. Конфликт интересов: о потенциальном конфликте интересов не сообщалось.
Поступила в редакцию 20.05.2022 Received 20.05.2022
Поступила после рецензирования 02.06.2022 Revised 02.06.2022 Принята к публикации 02.06.2022 Accepted 02.06.2022
ИНФОРМАЦИЯ ОБ АВТОРАХ
Barno F. Mukhamedova, Doctor of Medical Sciences, Deputy Director for Medical Work of the Republican Research Centre of Emergency Medicine, Tashkent, Uzbekistan
Shukhrat N. Salakhitdinov, Doctor of Philosophy (PhD) in Medical Sciences. Head of the Department of Angiography of the Republican Research Centre of Emergency Medicine, Tashkent, Uzbekistan
Maftuna Kh. Nazarova, Doctor of Philosophy (PhD) in Medical Sciences. Head of the Department of Emergency Cardiology and Therapy № 1, of the Republican Research Centre of Emergency Medicine, Tashkent, Uzbekistan
Bekhzodbek O. Kazakov, 2nd year basic doctoral student of the Republican Research Centre of Emergency Medicine. Tashkent, Uzbekistan
INFORMATION ABOUT THE AUTHORS
Мухамедова Барно Фархадовна, доктор медицинских наук, заместитель директора по лечебной работе, Республиканский научный центр экстренной медицинской помощи, г. Ташкент, Узбекистан
Салахитдинов Шухрат Нажмитдинович, доктор медицинских наук, заведующий отделением ангиографии, Республиканский научный центр экстренной медицинской помощи, г. Ташкент, Узбекистан
Назарова Мафтуна Хамидуллаевна, доктор медицинских наук, заведующий отделением неотложной кардиолгии и терапией № 1, Республиканский научный центр экстренной медицинской помощи, г. Ташкент, Узбекистан
Казаков Бехзодбек Озодбоевич, докторант II курса базовой докторантуры, Республиканский научный центр экстренной медицинской помощи, г. Ташкент, Узбекистан
